Synovial inflammatory macrophage-derived extracellular vesicles exacerbate cartilage lesions with a FMRP-selectively sorted manner in osteoarthritis
Top Cited Papers
Open Access
- 17 February 2026
- journal article
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 26
Abstract
Osteoarthritis (OA) is an aging-related degenerative joint disease without effective therapies. In the early stage of OA, mild synovitis has been reported to induce cartilage lesions. A better understanding of crosstalk between synovial macrophages and chondrocytes are being developed to discover new OA therapeutics. Here, we identified that the extracellular vesicles (EVs) derived from synovial pro-inflammatory macrophages regulated the autophagy function of chondrocytes, induced the onset of cartilage degeneration in normal joints. Mechanistically, the active transfer of miR-155-5p via EVs from synovial pro-inflammatory macrophages to chondrocytes accelerates cartilage degeneration by suppressing GSK-3β/mTORC1 axis-mediated autophagy function during OA progression. Deleting miR-155 from synovial pro-inflammatory macrophages relieved cartilage lesions and synovitis in OA mice. On the other hand, Fragile X mental retardation protein (FMRP) selectively sorted miR-155-5p into EVs derived from synovial pro-inflammatory macrophages, and the levels of plasma EVs FMRP were closely related to OA progression, suggesting the potential candidate for diagnostic OA biomarkers. Based on these findings, we developed engineering EVs with MAP (pro-inflammatory macrophages-affinity peptide) derived from adipose-derived stromal cells (ADSCs) as the antagomiR-155-5p delivery vehicles which exhibited superior therapeutic effects on synovitis and injured cartilage in the surgery-induced OA rats. Furthermore, MAP-ADSCs-EVs were proved to target the polarization of synovial pro-inflammatory macrophages in the clinical OA samples. Collectively, our study indicates that plasma EVs FMRP and engineered MAP-ADSCs-EVs targeting synovial pro-inflammatory macrophages represent potential novel therapeutic strategy for the progression of OA.Keywords
This publication has 90 references indexed in Scilit:
- Excessive mechanical loading promotes osteoarthritis development by upregulating Rcn2Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- Inflammatory Fibroblast‐Like Synoviocyte‐Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage GlycolysisAdvanced Science, 2024
- A Novel Cargo Delivery System‐AnCar‐ExoLaIMTS Ameliorates Arthritis via Specifically Targeting Pro‐Inflammatory MacrophagesAdvanced Science, 2023
- Evaluation and Treatment of Knee PainJAMA, 2023
- Prochondrogenic effect of decellularized extracellular matrix secreted from human induced pluripotent stem cell-derived chondrocytesActa Biomaterialia, 2023
- Noncanonical Pyroptosis Triggered by Macrophage‐Derived Extracellular Vesicles in Chondrocytes Leading to Cartilage Catabolism in OsteoarthritisArthritis & Rheumatology, 2023
- Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signalingActa Pharmaceutica Sinica B, 2022
- MicroRNA‐146a sponge therapy suppresses neointimal formation in rat vein graftsIUBMB Life, 2018
- Essential role of microRNA‐155 in the pathogenesis of autoimmune arthritis in miceArthritis & Rheumatism, 2011
- Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritisArthritis & Rheumatism, 2008